Infosys Ltd header image

Infosys Ltd

INFY

Equity

ISIN US4567881085 / Valor 516529

New York Stock Exchange, Inc (2024-11-21)
USD 21.96-0.14%

Infosys Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Infosys Ltd is a global leader in next-generation digital services and consulting, headquartered in India. The company specializes in helping clients navigate their digital transformation journey, leveraging technology to create new avenues of value and efficiency. Infosys offers a broad spectrum of services and solutions in areas such as IT, business consulting, and outsourcing services. With a strong emphasis on innovation and technology leadership, Infosys is known for its commitment to quality and excellence in delivering complex enterprise solutions. The company operates across various industries, providing tailored IT solutions that address the unique challenges of each sector. Despite the source's focus on talent transformation and internal initiatives, Infosys's core business revolves around enabling businesses around the world to enhance their performance and competitiveness through digital innovation and seamless technology integration.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (20.08.2024):

Revenue Growth

Infosys Ltd reported revenues of $4,714 million for Q1 2024, reflecting a sequential growth of 3.6% and a year-on-year growth of 2.5% in constant currency terms. This performance underscores the company's robust growth trajectory in the digital services and consulting sector.

Operating Margin

The operating margin for Infosys Ltd in Q1 2024 stood at 21.1%, marking a sequential expansion of 1%. This improvement is attributed to the company's relentless drive on cost optimization through Project Maximus, a comprehensive margin expansion program.

Free Cash Flow

Infosys Ltd achieved its highest ever free cash flow at $1,094 million in Q1 2024, representing a significant increase of 56.5% year over year. This milestone highlights the company's strong cash generation capabilities and efficient financial management.

Large Deal Wins

In Q1 2024, Infosys Ltd secured a record number of large deals, totaling 34 with a total contract value (TCV) of $4.1 billion. Notably, 57.6% of these deals were net new, showcasing the company's ability to attract and secure substantial new business.

FY25 Guidance

For the fiscal year 2025, Infosys Ltd has provided a revenue growth guidance of 3%-4% in constant currency terms. Additionally, the company has set an operating margin guidance range of 20%-22%, reflecting its confidence in maintaining strong financial performance.

Summarized from source with an LLMView Source

Key figures

25.9%1Y
-6.91%3Y
122%5Y

Performance

22.8%1Y
26.6%3Y
30.3%5Y

Volatility

Market cap

90959 M

Market cap (USD)

Daily traded volume (Shares)

1,135,850

Daily traded volume (Shares)

1 day high/low

22.03 / 21.77

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Grifols, SA
Grifols, SA Grifols, SA Valor: 30689493
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%EUR 10.40
Santhera Pharmaceuticals Holding Ltd.
Santhera Pharmaceuticals Holding Ltd. Santhera Pharmaceuticals Holding Ltd. Valor: 127602882
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.05%CHF 7.90
Kanzhun Limited
Kanzhun Limited Kanzhun Limited Valor: 111844659
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 6.25
Softing AG
Softing AG Softing AG Valor: 1080222
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.70%EUR 3.60
Vera Therapeutics Inc
Vera Therapeutics Inc Vera Therapeutics Inc Valor: 111319498
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.80%USD 47.03
Coursera Inc
Coursera Inc Coursera Inc Valor: 110443413
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.29%USD 6.98
NOVA LTD
NOVA LTD NOVA LTD Valor: 1072167
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.18%USD 179.72
Maplebear Inc
Maplebear Inc Maplebear Inc Valor: 129329749
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.02%USD 43.25
Fuji Soft KK
Fuji Soft KK Fuji Soft KK Valor: 514129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%JPY 9,550.00
KK KOKUSAI ELECTRIC
KK KOKUSAI ELECTRIC KK KOKUSAI ELECTRIC Valor: 129802396
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.60%JPY 2,195.00